FDA Approves Zurzuvae: First Oral Medication for Postpartum Depression (PPD)
The U.S. Food and Drug Administration (FDA) has given its stamp of approval to Zurzuvae (zuranolone), marking it as the first oral medication specifically designed to treat postpartum depression (PPD) in adults. PPD is a
Read More